| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
Electromed, Inc.$45.65
-0.17 (-0.37%)
F 17Pipeline Score MedTech · Pre-Clinical
Market Cap
316.46 M
EPS
1.22
P/E Ratio
32.84 $
Value Trade
1.65 M
SEC Financials
Q1 2026Dilution Risk
Revenue
18.57 M
R&D Expenses
361.00 K
Total Assets
59.47 M
Total Liabilities
10.31 M
Equity
49.17 M
D/E Ratio
12,345
6.4 %
Week
51.25 %
1 Month
59.52 %
3 Month
51.85 %
6 Month
286.45 %
5 Year
843.7 %
All Time
Cash Data
Cash Position
16.98 M
Monthly Burn
-
Runway
12,345 mo
Burn Trend
StableSEC Filing
May 12, 2026
Overview
Volume
585.72 K
52 Week Range
17.73 - 39.65
% held by Insiders
17.21 %
% held by Institutions
57.3 %
Enterprise Value
299.48 M
Total Shares
8.28 M
Short %
2.81 %
Float Shares
6.28 M
Company Description
locked
Upcoming Catalyst
Drug Pipeline Intelligence
F17
Pipeline Score -
Pipeline ValueValuation Signal
0
Drugs Scored—
rNPV / MCap Top 16%
Micro Cap (rank 766 of 911)
Percentile RankElectromed, Inc. has significant pipeline risk (17/100).
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in ELMD
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
ELMD Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
| 2026-07-17 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-07-17 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-07-17 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
ELMDBeyond the Pill: Why Medications for Bronchiectasis Benefit From a Natural Approach
The recent FDA approval of Brinsupri (brensocatib) offers new hope for bronchiectasis patients by reducing flare-ups. However, experts emphasize the importance of combining this medication with natural airway clearance therapies, such as SmartVest, to effectively manage mucus buildup. This comprehensive approach aims to improve overall lung health and quality of life for patients.
Read more →ELMDShould I Get a SmartVest?
The article discusses the benefits of using SmartVest for individuals with chronic lung conditions like bronchiectasis and COPD. It highlights the importance of effective airway clearance and when to consider HFCWO therapy. Clinical research indicates that SmartVest can significantly reduce hospitalizations and improve quality of life. Patients are encouraged to consult with their healthcare providers about their treatment options.
Read more →ELMDWhat Does Clear Phlegm Mean?
The article discusses the significance of clear phlegm, indicating it is usually a sign of normal bodily function. However, increased production can suggest underlying issues such as viral infections, allergies, or chronic respiratory conditions. The article provides management tips and advises consulting a healthcare professional if symptoms persist.
Read more →ELMDThe Evolution of HFCWO Therapy
High frequency chest wall oscillation (HFCWO) therapy, exemplified by the SmartVest, offers significant benefits for patients with chronic pulmonary diseases like bronchiectasis and COPD. This therapy uses vibrations to clear mucus from the lungs, reducing reliance on manual techniques. SmartVest has evolved since its inception, introducing portable devices and features that enhance patient care and independence.
Read more →ELMDWhat Is Chest Physiotherapy?
Chest physiotherapy (CPT) is a treatment designed to help clear mucus from the lungs, improving breathing for individuals with chronic lung conditions. Techniques include manual methods, postural drainage, and mechanical devices like SmartVest. These methods aim to reduce the risk of infection and enhance lung function. Regular use of CPT can lead to significant health improvements.
Read more →ELMDNew Treatments for Bronchiectasis
Recent advancements in bronchiectasis treatment include the FDA-approved drug Brinsupri, which targets lung inflammation. Additionally, ongoing clinical trials by companies like Boehringer Ingelheim aim to explore further therapies. The role of vitamin D in improving patient outcomes is also being investigated, highlighting a multifaceted approach to treatment.
Read more →ELMDSmoking and COPD: Should I Quit Smoking?
Chronic Obstructive Pulmonary Disease (COPD) affects millions and is primarily caused by smoking. Smoking damages lung tissue and increases the risk of flare-ups, making COPD symptoms worse. Quitting smoking can slow disease progression and improve quality of life, with immediate health benefits. Strategies for quitting include behavioral counseling and nicotine replacement therapy.
Read more →ELMDCOPD and Cold Weather Tips: Protect Your Lungs this Winter
The article discusses the challenges of managing COPD during cold weather and offers practical tips to protect lung health. It emphasizes the impact of cold air on respiratory conditions and suggests measures such as dressing warmly, avoiding triggers, and maintaining indoor air quality. Vaccinations and good hygiene practices are also recommended to prevent respiratory infections.
Read more →ELMDCommon Causes of Bronchiectasis
Bronchiectasis is a lung condition affecting up to 500,000 adults in the U.S., primarily caused by damage from infections or inflammation. Common causes include COPD, genetic disorders, and repeated lung infections. Although not contagious, individuals with bronchiectasis face higher infection risks. Effective treatments like SmartVest are available to help manage symptoms.
Read more →ELMDPhlegm vs. Mucus: Why the Difference Matters
The article explains the differences between mucus and phlegm, highlighting their unique roles in respiratory health. Mucus serves as a protective layer, while phlegm is a thicker mucus produced in response to irritants. The article also discusses the significance of phlegm color and offers airway clearance techniques for managing excessive mucus production, particularly in conditions like bronchiectasis.
Read more →ELMDVeterans with Bronchiectasis: Airway Clearance Treatment and VA Disability Ratings
The article discusses the impact of bronchiectasis on veterans, highlighting its connection to military service-related exposures. It outlines the VA disability ratings for bronchiectasis and related respiratory conditions, emphasizing the importance of airway clearance therapies like HFCWO. The SmartVest system is presented as a user-friendly solution for managing bronchiectasis, covered by many insurance plans, including VA. Veterans are encouraged to seek support for treatment and benefits.
Read more →ELMDRespiratory Care Week 2025
Respiratory Care Week 2025, running from October 19th to 25th, celebrates the vital contributions of respiratory care professionals. Coinciding with Healthy Lung Month, the event promotes awareness about respiratory health and encourages community engagement. Resources and support are available for patients and caregivers to manage chronic lung conditions effectively.
Read more →ELMDVeterans with Cystic Fibrosis
The article discusses the challenges faced by veterans with cystic fibrosis (CF) in accessing VA benefits and healthcare. It explains how CF is rated by the VA and the criteria used to determine disability ratings. Additionally, it highlights the importance of understanding the condition's impact on daily life and the complexities involved in navigating VA support.
Read more →ELMDVest Therapy vs. DPP1 Inhibitors: What to Know
The article discusses two treatment options for chronic respiratory conditions: vest therapy and DPP1 inhibitors. Vest therapy, a non-invasive method, helps clear mucus and improve lung function, while DPP1 inhibitors target inflammation at the cellular level. Both approaches can be combined for effective management of conditions like bronchiectasis and cystic fibrosis. Treatment should be tailored to individual patient needs.
Read more →ELMDWhy Does It Feel Like My Lungs Are Burning?
The article discusses the causes and treatments for a burning sensation in the lungs. Common causes include respiratory infections, allergies, and exposure to irritants like smoke and pollution. It outlines symptoms associated with this sensation and suggests treatment options, including medications, lifestyle changes, and home remedies. Consulting a clinician is recommended for persistent symptoms.
Read more →ELMDHow HFCWO Addresses the Vicious Vortex of Bronchiectasis
The article discusses bronchiectasis, a chronic lung condition characterized by a cycle of infection, inflammation, and lung damage. It emphasizes the role of high-frequency chest wall oscillation (HFCWO) therapy, particularly using the SmartVest, in managing symptoms and breaking this cycle. The article outlines various strategies, including airway clearance techniques and vaccinations, to improve lung function and reduce infections.
Read more →ELMDChronic Respiratory Conditions: The Best Sleeping Position to Clear Lungs
The article discusses the importance of sleeping positions for individuals with chronic respiratory conditions like COPD and cystic fibrosis. It outlines several recommended positions, including head and chest elevation and lying on the side, to facilitate mucus drainage and improve breathing. The piece emphasizes the role of sleep quality in managing respiratory health.
Read more →ELMDBest Sleeping Positions for Bronchiectasis
The article discusses effective sleeping positions for individuals with bronchiectasis, emphasizing the importance of posture in managing symptoms like coughing and mucus buildup. Recommended positions include sleeping with an elevated upper body, side-sleeping, and prone positions, each offering specific benefits for lung health. Additional tips for improving sleep quality are also provided, including the use of humidifiers and maintaining a consistent sleep routine.
Read more →ELMDNatural Treatment for the Vicious Vortex Through HFCWO
The article discusses the challenges of managing chronic lung conditions characterized by mucus buildup and infections. It highlights High-Frequency Chest Wall Oscillation (HFCWO) as a natural treatment option, specifically through the SmartVest device. This therapy aids in airway clearance, improving lung function and reducing reliance on medications. Patients using SmartVest report significant benefits, including fewer hospital visits and enhanced quality of life.
Read more →ELMDStop the Vicious Vortex Through Multiple Points: Why You Need Comprehensive Treatment
The article emphasizes the importance of a comprehensive treatment strategy for managing bronchiectasis and other chronic respiratory conditions. It describes the 'vicious vortex' of symptoms and how interventions like airway clearance therapy, medication, and lifestyle changes can break this cycle. SmartVest therapy is highlighted as a key tool in this management approach, improving quality of life and reducing hospital visits.
Read more →ELMDWhat Disease Causes Excessive Mucus Production
Excessive mucus production can stem from various diseases, impacting respiratory health. Conditions such as COPD, bronchiectasis, cystic fibrosis, and asthma are notable causes. Effective management strategies, including airway clearance techniques like SmartVest, can help alleviate symptoms and improve lung function. Understanding these conditions is crucial for effective treatment.
Read more →ELMDCoughing Fits: Causes and How to Find Relief
Coughing fits, characterized by intense and uncontrollable coughing, can signal underlying health issues such as bronchiectasis or asthma. Various types of coughs exist, including dry, wet, acute, and chronic coughs, each with different causes. Effective management strategies include hydration, avoiding irritants, and following treatment plans for chronic conditions. Persistent coughing fits warrant medical evaluation, especially if accompanied by concerning symptoms.
Read more →ELMD▲ +6.4%on this news
What Foods Help Reduce Mucus in the Lungs?
The article discusses the impact of diet on mucus production in the lungs. It highlights foods that can exacerbate mucus, such as processed foods and dairy, while recommending options like salmon, celery, and broth-based soups to help reduce mucus. Hydration is emphasized as crucial for individuals with chronic lung conditions. The article also advises consulting healthcare professionals before making dietary changes.
Read more →ELMD▲ +6.4%on this newsshared move
Alcohol and Bronchiectasis: What You Need to Know
The article discusses the impact of alcohol consumption on individuals with bronchiectasis, a chronic lung condition. It highlights how both moderate and excessive alcohol intake can exacerbate symptoms by increasing mucus production and impairing immune function. The article also suggests healthy alternatives to alcohol that can support lung health and encourages individuals to consult healthcare providers regarding alcohol use.
Read more →ELMDHow to Get Rid of Mucus Buildup in the Lungs
The article discusses mucus buildup in the lungs, its causes, and effective natural remedies. It highlights symptoms like wheezing and chest congestion, and suggests hydration, steam inhalation, and dietary changes as relief methods. For chronic lung conditions, the SmartVest device is recommended to aid in mucus clearance. Consulting a healthcare professional is advised for persistent symptoms.
Read more →ELMDAirway Clearance Device for Veterans
The article discusses the importance of airway clearance therapy for veterans suffering from COPD, highlighting how devices like SmartVest can aid in improving lung function and overall health. It outlines the VA's guidelines for COPD management and the process for veterans to apply for benefits related to their condition. The focus is on ensuring veterans receive the best possible care for their respiratory issues.
Read more →ELMDDATED MARCH 10, 2025 FOR IMMEDIATE RELEASE Electromed, Inc. Announces Share Repurchase Authorization NEW PRAGUE, Minn. (
Electromed, Inc. has authorized a share repurchase program for up to $5.0 million, aimed at enhancing shareholder value. The company's management believes using excess cash for stock buybacks is a prudent decision that will maintain strong financial performance while allowing for future investments. The actual timing and amount of repurchases will depend on market conditions, with the board noting the potential risks involved in forward-looking statements regarding the company's financial position.
Read more →ELMDOverproduction of Mucus: What to Do
The article discusses mucus overproduction in the respiratory system, detailing its causes, effects, and management strategies. It highlights chronic conditions like COPD and asthma as significant contributors to excessive mucus. The article also emphasizes the importance of lifestyle changes and tools like SmartVest for effective management. Persistent mucus issues may require medical evaluation to address underlying conditions.
Read more →ELMDCan HFCWO Therapy Help Reduce Antibiotics Usage?
The article discusses the potential of SmartVest therapy in reducing antibiotic usage and associated costs for patients with chronic lung conditions like COPD and bronchiectasis. A clinical study indicated that using SmartVest led to significant decreases in hospitalization and antibiotic costs. Electromed emphasizes their commitment to patient support and financial assistance.
Read more →ELMDElectromed, Inc. Announces Record Financial Performance in Fiscal 2025 Second Quarter Company maintained strong momentum to deliver another quarter of record revenue and earnings, while continuing to invest in multiple s
Electromed, Inc. reported record financial results for the second quarter of fiscal 2025, with net revenues rising 18.7% to $16.3 million compared to the same period last year. The company's impressive performance was driven by increases in referrals and efficiencies in its direct-to-patient model. Operating income also reached a record $2.5 million, highlighting effective cost management along with revenue growth. Electromed continues to invest in strategic initiatives to enhance productivity and operational efficiency.
Read more →ELMD▼ -7.2%on this newsshared move
What Is HFCWO Therapy?
High-Frequency Chest Wall Oscillation (HFCWO) is a non-invasive therapy designed for individuals with chronic respiratory conditions. It utilizes devices like SmartVest to create vibrations that help clear mucus from the airways, improving lung function and reducing infection risks. The therapy is convenient, allowing patients to perform it at home, and is particularly beneficial for conditions such as bronchiectasis and cystic fibrosis.
Read more →ELMDWhy is Bronchiectasis Worse in Winter?
The article discusses how winter exacerbates bronchiectasis symptoms due to cold, dry air that irritates the lungs and increases infection risk. It emphasizes the importance of proactive management strategies, such as staying active, hydrating, and using airway clearance devices like SmartVest. These measures can help patients maintain better respiratory health during the colder months.
Read more →ELMDAirway Clearance Devices: Understanding Their Benefits and Uses
The article discusses the importance of airway clearance devices for individuals with chronic lung conditions like bronchiectasis and COPD. It highlights various methods of airway clearance, including breathing techniques and devices such as OPEP and SmartVest. The SmartVest offers a non-invasive, effective solution for mucus clearance, improving overall lung health and reducing infection risks.
Read more →ELMDAir Trapped in Lungs: Causes and Remedies
The article discusses air trapping in the lungs, a condition often linked to diseases like COPD, asthma, and bronchiectasis. It highlights the causes, symptoms, and management strategies, including bronchodilators, inhaled steroids, and breathing exercises. The importance of medical evaluation for proper diagnosis and treatment is emphasized.
Read more →ELMDCan Cold Air Cause Cough & Chest Pain?
The article discusses how cold air can affect respiratory health, particularly for individuals with conditions like COPD and bronchiectasis. It explains that cold, dry air can lead to coughing, chest pain, and other respiratory issues. The article also offers tips for managing symptoms during winter and emphasizes the importance of consulting healthcare providers for effective management strategies.
Read more →ELMDCoughing Up Blood With Bronchiectasis
The article discusses bronchiectasis, a chronic lung condition that can lead to hemoptysis, or coughing up blood. It outlines the causes of this symptom, including chronic infections and airway damage. Treatment options such as antibiotics, airway clearance therapy, and bronchial artery embolization are explored. Preventive measures and the benefits of using SmartVest for home therapy are also highlighted.
Read more →ELMDElectromed, Inc. Announces Fiscal 2025 First Quarter Financial Results Electromed delivers eighth consecutive quarter of year-over-year revenue and profit growth, while continuing to invest in strategic growth initiative
Electromed, Inc. announced its financial results for the first quarter of fiscal 2025, ending September 30, 2024, demonstrating strong performance with a 19% year-over-year revenue growth to $14.7 million. The company’s profit also increased significantly, reaching $11.5 million, attributed to higher sales and efficiencies in operations. Additionally, Electromed continues to expand its sales force and territories and launched a new marketing campaign to enhance its bronchiectasis treatment offerings. The overall financial health is solid, with no debt and a cash reserve of $13.9 million.
Read more →ELMDWhy Does My Chest Hurt When I Lie Down?
The article discusses the sensation of chest tightness when lying down, exploring various causes such as anxiety, chronic respiratory conditions, heart issues, and acid reflux. It emphasizes the importance of recognizing accompanying symptoms and when to seek medical advice. Additionally, it suggests home remedies for relief and treatment options for underlying conditions.
Read more →ELMDDoes Bronchiectasis Cause Bad Breath?
Bronchiectasis is linked to bad breath due to mucus buildup and bacterial growth in the lungs. This condition can lead to foul-smelling sputum, which is a result of chronic infections and inflammation. Maintaining good oral hygiene and managing mucus buildup are essential for reducing symptoms. Consulting a healthcare provider is crucial for proper diagnosis and treatment.
Read more →ELMDHow Does Coffee Affect People with a Chronic Lung Condition?
The article explores the effects of caffeine, particularly from coffee, on individuals with chronic lung conditions like bronchiectasis and COPD. While caffeine may act as a weak bronchodilator and reduce asthma symptoms, it can also lead to dehydration and interfere with certain medications. Patients are advised to consult their clinicians regarding caffeine consumption and its potential effects on their treatment plans.
Read more →ELMD▲ +5%on this news
What is the Vortex of Bronchiectasis?
Bronchiectasis is a chronic lung condition characterized by the permanent dilation of the bronchi, leading to a cycle of infection, inflammation, and lung damage. This article discusses the 'vicious vortex' of bronchiectasis, emphasizing the need for early detection and a multifaceted treatment approach. Techniques such as airway clearance and antibiotic therapy are highlighted as essential for breaking the cycle and improving patient outcomes.
Read more →ELMDBronchiectasis: Foods to Avoid
The article discusses the impact of diet on managing bronchiectasis symptoms. It highlights specific foods to avoid, such as fried foods, processed meats, and sugary beverages, which can worsen inflammation and mucus production. Conversely, it suggests incorporating nutrient-rich foods and staying hydrated to support lung health. Consulting a healthcare provider for personalized dietary advice is recommended.
Read more →ELMDElectromed, Inc. Announces Share Repurchase Authorization NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. ("Electromed") (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced
Electromed, Inc. has announced a new share repurchase authorization of up to $5 million, effective September 11, 2024. This decision follows the exhaustion of a previous repurchase program and is supported by the company's recent record performance in fiscal 2024. The management has emphasized strong revenue growth and profitability, which contributes to significant free cash flow. This strategic move reflects the board's confidence in the company's future growth and intent to enhance shareholder value.
Read more →ELMD▲ +6.9%on this news
Electromed, Inc. Announces Record Fiscal Year 2024 Financial Results Record Q4 and full year financial results NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. ("Electromed") (NYSE American: ELMD), a leader in innov
Electromed, Inc. reported record financial results for fiscal year 2024, with total revenues increasing by 13.8% to $54.7 million. The company also saw a significant increase in operating income and net income per share, driven by growth in its direct homecare and hospital markets. Despite challenges such as the expiration of the CMS waiver, Electromed continued to invest in growth and gained market share throughout the year. The company aims to build on this momentum as it prepares for fiscal year 2025.
Read more →ELMDWhat Is a Productive Cough?
The article explains the differences between productive and non-productive coughs, highlighting how a productive cough helps clear mucus from the lungs. It details the causes and treatments for both types of coughs, emphasizing the importance of seeking medical attention for persistent symptoms. Home remedies and airway clearance techniques are also discussed.
Read more →ELMDWhat is Bronchiectasis in the Lungs
Bronchiectasis is a chronic lung condition characterized by the abnormal widening and inflammation of the airways, leading to mucus buildup and frequent infections. It affects 350,000 to 500,000 adults in the U.S., with symptoms varying from persistent cough to shortness of breath. While there is no cure, treatments like supportive therapy and devices such as SmartVest can help manage symptoms and improve quality of life.
Read more →ELMDInvestor Presentation Electromed, Inc. Investor Presentation August 2024 NYSE American: ELMD Innovation Leader in Airway Clearance Technologies | 2 Investor Presentation Forward Looking Statements Certain statements in
Electromed, Inc. (NYSE American: ELMD) presented its investor overview for August 2024, emphasizing its position as an innovation leader in airway clearance technologies. The company reported strong financial metrics and an expanding market for its SmartVest airway clearance system. Forward-looking statements indicate that while there are significant growth opportunities, uncertainties exist, particularly related to regulatory compliance and market competition. Electromed is focused on enhancing market penetration and improving sales channels for its products.
Read more →ELMDBronchiectasis Supportive Therapy for Patients
The article discusses the importance of supportive therapy for managing bronchiectasis, a chronic respiratory condition. It outlines five key components of an effective therapy program, including medication management, breathing exercises, nutritional support, and the use of the SmartVest Airway Clearance System. The article emphasizes the need for personalized treatment plans to improve patient outcomes and quality of life.
Read more →ELMDBronchiectasis and Asthma: Is There a Higher Chance of Comorbidity?
Recent studies indicate a significant overlap between bronchiectasis and asthma, particularly in patients with severe asthma symptoms. This overlap, termed asthma-bronchiectasis overlap syndrome (ABOS), poses diagnostic challenges and may lead to inadequate treatment. New research highlights the prevalence of bronchiectasis in asthma patients, emphasizing the need for tailored treatment plans. Proper diagnosis often requires specialized imaging techniques.
Read more →ELMDHow Posture Can Support Airway Clearance
The article discusses the significant impact of posture on respiratory health, particularly for individuals with chronic lung conditions. It explains how good posture can enhance diaphragm mobility, thereby improving lung capacity and airway clearance. Practical tips for maintaining proper posture while sitting, standing, and sleeping are provided to help individuals manage their breathing more effectively.
Read more →ELMDObstructive vs. Restrictive Lung Disease: What’s The Difference?
The article explains the differences between obstructive and restrictive lung diseases, detailing their causes, symptoms, and treatment options. Obstructive diseases, such as COPD and asthma, involve airflow blockages, while restrictive diseases affect lung capacity. It emphasizes the importance of diagnosis and management for improving patient quality of life.
Read more →ELMD▼ -14.9%on this news
5 Bronchiectasis Airway Clearance Techniques
The article discusses five effective airway clearance techniques for managing bronchiectasis, emphasizing their importance in improving lung function and overall quality of life. Techniques include High Frequency Chest Wall Oscillation (HFCWO) therapy, coughing and huffing, Oscillating Positive Expiratory Pressure (OPEP), Manual Chest Physiotherapy (CPT), and Autogenic Drainage. The article highlights the benefits of regular airway clearance in preventing infections and enhancing oxygen flow.
Read more →ELMDCystic Fibrosis vs. Pulmonary Fibrosis
The article compares cystic fibrosis (CF) and pulmonary fibrosis (PF), emphasizing their distinct causes, symptoms, and treatments. CF is a genetic disorder leading to mucus buildup in the lungs, while PF involves scarring of lung tissue. Both conditions require tailored treatment plans to manage symptoms and improve quality of life. Support resources are also discussed.
Read more →ELMDElectromed, Inc. Announces Record Revenue in Fiscal 2024 Third Quarter Growth initiatives drive record revenue NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. ("Electromed") (NYSE American: ELMD), a leader in innov
Electromed, Inc. reported record revenues of $13.9 million for the third quarter of fiscal 2024, marking a 14.9% increase from the previous year. Operating income also rose significantly to $1.493 million, reflecting solid performance and strategic growth initiatives. The company continues to enhance its sales force, which has contributed to robust profitability and efficiency in service delivery. With a strong cash position and no debt, Electromed aims to maintain this positive momentum into the final quarter of the fiscal year.
Read more →ELMD▲ +6%on this news
What Is a Flare Up?
The article explains the terms 'flare-up' and 'acute exacerbation' in the context of chronic lung diseases such as COPD and bronchiectasis. It discusses the symptoms, triggers, and management strategies for these conditions. Emphasizing the importance of early intervention, the article also introduces the SmartVest Airway Clearance System as a therapeutic option for patients.
Read more →ELMDBronchiectasis Complications
Bronchiectasis is a chronic lung condition that can lead to serious complications if not properly diagnosed and managed. The article discusses the risks associated with bronchiectasis, including recurrent infections and the impact on lung function. It highlights the importance of early detection and proactive management, as well as treatment options like the SmartVest Airway Clearance System to help patients manage their symptoms effectively.
Read more →ELMDMorning Cough: Causes and Home Remedies
The article discusses the common causes of morning cough, which can range from allergies to chronic conditions like asthma and bronchitis. It emphasizes the importance of recognizing symptoms and seeking medical attention if the cough persists. Additionally, several home remedies are suggested to alleviate symptoms, including hydration and using humidifiers.
Read more →ELMDWheezing and Crackling Sounds in the Lungs
The article discusses the causes and treatments for wheezing and crackling sounds in the lungs. Wheezing occurs due to narrowed airways, often linked to allergies or respiratory conditions, while crackling indicates fluid in the lungs. Treatment varies based on the underlying cause, including lifestyle changes and medications. The SmartVest Airway Clearance System is highlighted as a potential aid for chronic lung conditions.
Read more →ELMDDisorders of the Diaphragm: Types, Symptoms & Treatment
The article discusses diaphragm disorders, their types, causes, symptoms, and diagnosis. It highlights a case study of a patient with post-COVID-19 diaphragmatic paralysis who benefited from SmartVest therapy. The therapy led to significant symptom improvement and better lung function, showcasing its potential in managing respiratory issues effectively.
Read more →ELMD▲ +9.1%on this news
Bronchiectasis vs. COPD: How Are They Different?
The article explains the differences between bronchiectasis and Chronic Obstructive Pulmonary Disease (COPD), highlighting their distinct causes, diagnostic methods, and treatment options. While both conditions share symptoms like cough and shortness of breath, they require different management strategies. The piece emphasizes the importance of accurate diagnosis to ensure appropriate treatment.
Read more →ELMDElectromed, Inc. Announces Record Financial Performance in Fiscal 2024 Second Quarter Growth initiatives drive record revenue, improve margins and enhance operational efficiency NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Elect
Electromed, Inc. (ELMD) reported record financial performance for the second quarter of fiscal 2024, with revenue increasing 17% to $13.7 million compared to the previous year. The operating income also reached a record high of $2.263 million, accounting for 16.5% of total revenue. The results were attributed to a growth in sales territories and improved efficiencies in the reimbursement process. Electromed continues to invest in its product offerings and customer service, aiming for sustained market growth in the coming quarters.
Read more →ELMDHRCT: The Gold Standard in Bronchiectasis Diagnosis
High-resolution computerized tomography (HRCT) is highlighted as the gold standard for diagnosing bronchiectasis, a chronic lung condition. While there is no cure, HRCT allows for accurate diagnosis and effective management of symptoms. The article discusses the differences between HRCT and other imaging techniques, emphasizing its advantages for lung assessments.
Read more →ELMDWhat Is NTM Lung Disease?
Nontuberculous Mycobacteria (NTM) can cause lung infections, particularly in individuals with pre-existing lung conditions. Symptoms include coughing, shortness of breath, and fatigue. Treatment options involve antibiotics and airway clearance therapies. Preventive measures, such as avoiding contaminated water sources, are crucial for at-risk individuals.
Read more →ELMDHow Serious Is Bronchiectasis?
Bronchiectasis is a chronic lung condition characterized by airway damage, leading to symptoms like persistent cough and shortness of breath. While there is no cure, effective management options, including antibiotics and therapies like HFCWO, can help control symptoms and improve quality of life. With proper treatment, patients can maintain a normal life expectancy despite the condition's challenges.
Read more →ELMDA Breath of Knowledge: Understanding the Anatomy of the Lungs
The article explores the anatomy and function of the respiratory system, detailing the roles of the lungs and throat in gas exchange. It emphasizes the importance of maintaining lung health through various lifestyle choices and provides practical tips for protecting respiratory function. Additionally, it introduces the SmartVest Airway Clearance System as a resource for managing lung conditions.
Read more →ELMDBronchiectasis vs. Bronchitis: How to Tell the Difference
The article discusses the differences and similarities between bronchiectasis and chronic bronchitis, two chronic respiratory conditions. It highlights the causes, symptoms, diagnosis, and treatment options for each condition. The SmartVest Airway Clearance System is presented as a helpful tool for managing symptoms and improving lung function. Understanding these distinctions is crucial for effective treatment and management.
Read more →ELMDTypes of Bronchiectasis: What You Need to Know
The article discusses bronchiectasis, a chronic lung condition characterized by damaged and widened airways. It highlights the different types of bronchiectasis, including Cystic Fibrosis Bronchiectasis and Non-Cystic Fibrosis Bronchiectasis. The SmartVest Airway Clearance System is presented as an effective treatment option that aids in mucus clearance and symptom management.
Read more →ELMD▼ -7.9%on this news
Electromed, Inc. Announces Fiscal 2024 First Quarter Financial Results NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. ("Electromed" or the "Company") (NYSE American: ELMD), a leader in innovative airway clearance
Electromed, Inc. reported financial results for the first quarter of fiscal 2024, highlighting a 16% increase in net revenue to $12.3 million compared to the same period last year. The growth was attributed to higher referrals, approvals, and reimbursement rates across all revenue categories, including homecare, hospital, and international. The company's gross profit reached $9.5 million, although gross margin decreased slightly due to rising costs. Operating income improved to $142,000, and net income rose to $155,000, reflecting overall successful operational execution.
Read more →ELMDCOPD Awareness Month
November is recognized as COPD Awareness Month, aiming to enhance public understanding of Chronic Obstructive Pulmonary Disease (COPD). The American Lung Association reports that over 12.5 million people in the U.S. are affected, with many unaware of their condition. The month emphasizes early detection and available therapies to manage symptoms and improve quality of life.
Read more →ELMDShould You See a Pulmonary Doctor?
The article emphasizes the importance of consulting a pulmonary doctor for persistent respiratory issues such as chronic cough, shortness of breath, and chest pain. It outlines the role of pulmonologists in diagnosing and treating various lung conditions, highlighting the benefits of early detection and specialized care. The article also discusses common symptoms that warrant a visit to a lung specialist and the types of diagnostic tests and treatments available.
Read more →ELMDHow Is Chest Physiotherapy Performed at Home?
The article discusses chest physiotherapy (CPT) techniques, emphasizing their importance for patients with chronic lung diseases like cystic fibrosis. It explains how manual CPT is performed and introduces the SmartVest Airway Clearance System as a more practical, independent alternative. SmartVest provides consistent therapy, allowing patients to manage their treatment effectively at home.
Read more →ELMDFind Relief from Smoke-Induced Lung Irritation
The article discusses the impact of smoke from wildfires on air quality and respiratory health. It highlights symptoms of smoke-induced lung irritation and offers home remedies for relief. The importance of monitoring the Air Quality Index (AQI) is emphasized, along with strategies to minimize exposure to smoke. The SmartVest Airway Clearance System is also introduced as a potential solution for managing lung health.
Read more →ELMD▲ +6.5%on this news· ran to +18% by day 1
Electromed, Inc. Announces Fiscal 2023 Fourth Quarter and Full Year Financial Results --Record Annual Revenue -- -- Fourth Quarter Revenue Increased 21% Year-Over-Year; Full Year Revenue Increased 15% -- NEW PRAGUE, Minn
Electromed, Inc. announced its financial results for the fourth quarter and the fiscal year ending June 30, 2023. The company achieved record revenues of $13.6 million for Q4, marking a 21% year-over-year increase, and an overall revenue increase of 15% to over $48 million for the fiscal year. Despite navigating difficulties such as the expiration of the CMS waiver and supply chain disruptions, Electromed launched its next-generation SmartVest Clearway device. Moving into FY 2024, the management plans to focus on sales force expansion and enhancing marketing strategies to support growth in the bronchiectasis treatment market.
Read more →ELMDAirway Obstruction: Signs, Symptoms, and Treatment
The article discusses airway obstruction, highlighting its causes, symptoms, and treatments. It emphasizes that conditions like COPD and bronchiectasis can lead to mucus buildup, obstructing airflow. The SmartVest Airway Clearance System is presented as an effective solution for managing lower airway obstruction. Recognizing signs of severe obstruction is crucial for timely medical intervention.
Read more →ELMDElectromed Names Jim Cunniff as President and Chief Executive Officer Healthcare Executive Brings More Than 30 Years of Executive Experience and Commercial Success to Electromed NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Elect
Electromed, a leader in airway clearance technologies, has appointed Jim Cunniff as its new President and Chief Executive Officer, effective July 1, 2023. Cunniff brings over 30 years of executive experience in the MedTech and healthcare sectors, having successfully led organizations like Provista and Stryker Corporation. He succeeds Kathleen Skarvan, who will continue as Chair of the Board after a decade of significant leadership at the company.
Read more →ELMDElectromed, Inc. Announces Fiscal 2023 Third Quarter Results Quarterly Net Revenue Increase of 19% Year-over-Year NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. ("Electromed") (NYSE American: ELMD), a leader in in
Electromed, Inc. announced its fiscal 2023 third quarter financial results, reporting a 19% year-over-year increase in net revenue, totaling $12.1 million. The revenue growth was attributed to a rise in referrals and improved sales team productivity. The company noted that their new SmartVest Clearway product has been well-received, contributing positively to their market position. However, they also recognized challenges such as increased material costs and temporary supply chain disruptions.
Read more →ELMDElectromed, Inc. Announces Fiscal 2023 Second Quarter Results Growth initiatives help drive record quarterly revenue NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. ("Electromed") (NYSE American: ELMD), a leader in
Electromed, Inc. announced strong financial results for the second quarter of fiscal year 2023, reporting a record revenue of $11.7 million, up 14.5% year-over-year. The company attributes this growth to expanded sales efforts and successful new product releases, notably the SmartVest Clearway, which has received positive feedback from patients. However, it faced challenges with rising material and shipping costs, which impacted its gross profit margin. Additionally, Electromed experienced a decline in international revenue by 41.9% compared to the previous year.
Read more →ELMDElectromed, Inc. Announces Fiscal 2023 First Quarter Results Continued Momentum on Key Growth Initiatives NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. ("Electromed" or the "Company") (NYSE American: ELMD), a lea
Electromed, Inc. Announces Fiscal 2023 First Quarter Results Continued Momentum on Key Growth Initiatives NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. ("Electromed" or the "Company") (NYSE American: ELMD), a leader in innovative airway clearance technologies, today a
Read more →ELMDElectromed, Inc. Appoints Brad Nagel as Chief Financial Officer Accomplished medical device leader to fill key strategic role NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. ("Electromed" or the "Company") (NYSE Am
Electromed, Inc. Appoints Brad Nagel as Chief Financial Officer Accomplished medical device leader to fill key strategic role NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. ("Electromed" or the "Company") (NYSE American: ELMD), a leader in innovative airway clearance
Read more →ELMDElectromed, Inc. Announces Fiscal 2022 Fourth Quarter and Full Year Financial Results --Record Annual Revenue and Growth Rate -- Fourth Quarter Revenue Increased 19% Year-Over-Year; Full Year Revenue Increased 16.5% -- L
Inc. Announces Fiscal 2022 Fourth Quarter and Full Year Financial Results Annual Revenue and Growth Rate Fourth Quarter Revenue Increased 19% Year-Over-Year; Full Year Revenue Increased 16.5% -- Leveraging Strategic Investments to Accelerate Growth -- PRAGUE, Minn.--(BUSINESS
Read more →ELMDElectromed, Inc. Announces Election of Andrew Summers as Additional Independent Director Electromed Also Enters into New Cooperation Agreement with Summers Value Partners and Expands Board to Eight Members Mr. Summers to
Inc. Announces Election of Andrew Summers as Additional Independent Director Also Enters into New Cooperation Agreement with Summers Value Partners and Expands Board to Eight Members Summers to serve as Vice Chair of the Finance and Strategy Committee PRAGUE, Minn., July 25, 2
Read more →ELMDElectromed, Inc. Announces Third Quarter Financial Results 15.4% revenue growth while continuing to execute key strategic initiatives Company also announces Chief Financial Officer transition NEW PRAGUE, Minn.
Inc. Announces Third Quarter Financial Results revenue growth while continuing to execute key strategic initiatives also announces Chief Financial Officer transition NEW PRAGUE, Minn. -- May 10, 2022 -- (BUSINESS WIRE) -- Electromed, Inc. ("Electromed" or the "Company") (NYSE
Read more →ELMDElectromed, Inc. Announces Second Quarter Financial Results -- Record quarterly net revenues of $10.2 million while continuing to execute key strategic growth initiatives -- New Prague, Minnesota
Electromed, Inc. Announces Second Quarter Financial Results -- Record quarterly net revenues of $10.2 million while continuing to execute key strategic growth initiatives -- New Prague, Minnesota - February 8, 2022 - Electromed, Inc. ("Electromed" or the "Company") (NYSE Americ
Read more →ELMDElectromed, Inc. Announces Fiscal 2022 First Quarter Financial Results -- Record quarterly revenue of $10.0 million, 25.0% growth vs. prior year driven by strong growth in home care and institutiona
Electromed, Inc. Announces Fiscal 2022 First Quarter Financial Results -- Record quarterly revenue of $10.0 million, 25.0% growth vs. prior year driven by strong growth in home care and institutional markets -- New Prague, Minnesota - November 9, 2021 - Electromed, Inc. ("Elect
Read more →ELMDElectromed, Inc. Announces Nominations of Kathy Tune and Joe Galatowitsch as New Independent Directors Enters into Cooperation Agreement with Summers Value Partners and Announces Formation of Financ
Announces Nominations of Kathy Tune and as New Independent Directors Cooperation Agreement with Summers Value Partners and Announces Formation of Finance and Strategy Committee to Review Value Creation Opportunities Steve Craney and George Winn to Retire from the Board at Upc
Read more →ELMDElectromed, Inc. Announces Fiscal 2021 Fourth Quarter and Full Year Financial Results -- Double-Digit Year over Year Revenue Growth -- -- Strong Operating Cash Flow -- -- Progress on Key Growth Init
Electromed, Inc. Announces Fiscal 2021 Fourth Quarter and Full Year Financial Results -- Double-Digit Year over Year Revenue Growth -- -- Strong Operating Cash Flow -- -- Progress on Key Growth Initiatives: Commercial Expansion, Strategic Marketing, Research & Development, Inf
Read more →ELMDElectromed, Inc. Announces Authorization of $3.0 Million Stock Repurchase Program New Prague, Minnesota
Electromed, Inc. Announces Authorization of $3.0 Million Stock Repurchase Program Prague, Minnesota - May 27, 2021 - Electromed, Inc. ("Electromed" or the "Company") (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that its Board of
Read more →ELMDElectromed, Inc. Announces Fiscal 2021 Third Quarter Financial Results -- Second Consecutive Quarter of Year over Year Growth, Continuing Profitability & Positive Cash Flow while Investing in Key St
Inc. Announces Fiscal 2021 Third Quarter Financial Results Second Consecutive Quarter of Year over Year Growth, Continuing Profitability & Positive Cash Flow while Investing in Key Strategic Initiatives -- Prague, Minnesota - May 11, 2021 - Electromed, Inc. ("Electromed" or th
Read more →ELMDElectromed, Inc. Announces Fiscal 2021 Second Quarter Financial Results -- 11.1% Net Revenue Growth, Driven by a 16.1% Increase in Home Care Revenue -- New Prague, Minnesota
Inc. Announces Fiscal 2021 Second Quarter Financial Results 11.1% Net Revenue Growth, Driven by a 16.1% Increase in Home Care Revenue -- Prague, Minnesota - February 9, 2021 - Electromed, Inc. ("Electromed" or the "Company") (NYSE American: ELMD), a leader in innovative airway
Read more →ELMDElectromed, Inc. Announces Fiscal 2021 First Quarter Financial Results -- 16.4% Sequential Revenue Growth Driven by Stronger Home Care Revenue -- New Prague, Minnesota
Inc. Announces Fiscal 2021 First Quarter Financial Results 16.4% Sequential Revenue Growth Driven by Stronger Home Care Revenue -- Prague, Minnesota - November 10, 2020 - Electromed, Inc. ("Electromed" or the "Company") (NYSE American: ELMD), a leader in innovative airway clea
Read more →ELMDCEO Letter to Shareholders Making life's important moments possible - one breath at a time. To My Fellow Shareholders: In a year marked by global turmoil with the onset of the COVID-19 pandemic, the entire Electromed tea
important moments possible - one breath at a time. In a year marked by global turmoil with the onset of the COVID-19 pandemic, the entire Electromed team demonstrated an unwavering commitment to flawlessly manufacturing and delivering our SmartVest Airway Clearance System. Des
Read more →ELMDElectromed, Inc. Announces Fiscal 2020 Fourth Quarter and Full Year Financial Results -- Record profitability: diluted EPS of $0.47 in fiscal 2020 versus $0.23 in fiscal 2019 -- New Prague, Minnesot
Inc. Announces Fiscal 2020 Fourth Quarter and Full Year Financial Results Record profitability: diluted EPS of $0.47 in fiscal 2020 versus $0.23 in fiscal 2019 -- Prague, Minnesota - August 25, 2020 - Electromed, Inc. ("Electromed" or the "Company") (NYSE American: ELMD), a le
Read more →ELMDElectromed, Inc. Appoints Michael J. MacCourt as Chief Financial Officer New Prague, Minnesota
Electromed, Inc. Appoints Michael J. MacCourt as Chief Financial Officer New Prague, Minnesota - May 18, 2020 - Electromed, Inc. ("Electromed" or the "Company") (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that its Board of Direct
Read more →ELMDElectromed, Inc. Announces Fiscal 2020 Third Quarter Financial Results -- 18.0% revenue growth from prior year period with net income of $0.7 million -- New Prague, Minnesota
Inc. Announces Fiscal 2020 Third Quarter Financial Results 18.0% revenue growth from prior year period with income of $0.7 million -- Prague, Minnesota - May 12, 2020 - Electromed, Inc. ("Electromed" or the "Company") (NYSE American: ELMD), a leader in innovative airway clear
Read more →ELMDElectromed, Inc. Announces CFO Transition New Prague, Minnesota
Electromed, Inc. Announces CFO Transition New Prague, Minnesota - March 4, 2020 - Electromed, Inc. ("Electromed" or the "Company") (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that CFO Jeremy Brock has elected to pursue other opp
Read more →ELMDElectromed, Inc. Announces Fiscal 2020 Second Quarter Financial Results -- Net income of $1.2 million driven by 6.7% revenue growth from prior year period and 18.3% operating margin -- New Prague, M
Electromed, Inc. Announces Fiscal 2020 Second Quarter Financial Results -- Net income of $1.2 million driven by 6.7% revenue growth from prior year period and 18.3% operating margin -- New Prague, Minnesota - February 11, 2020 - Electromed, Inc. ("Electromed" or the "Company")
Read more →ELMDElectromed, Inc. Announces Fiscal 2020 First Quarter Financial Results -- Net income of $1.0 million primarily driven by 14.1% revenue growth from prior year period and 16.2% operating margin -- New
Electromed, Inc. Announces Fiscal 2020 First Quarter Financial Results -- Net income of $1.0 million primarily driven by 14.1% revenue growth from prior year period and 16.2% operating margin -- New Prague, Minnesota - November 12, 2019 - Electromed, Inc. ("Electromed" or the "
Read more →ELMDElectromed, Inc. Announces Fiscal 2019 Fourth Quarter and Full Year Financial Results -- Fourth quarter results driven by 10.1% year-over-year growth in home care revenue and operating margin improv
Inc. Announces Fiscal 2019 Fourth Quarter and Full Year Financial Results Fourth quarter results driven by 10.1% year-over-year growth in home care revenue and operating margin improvement to 17.3% -- Prague, Minnesota - August 27, 2019 - Electromed, Inc. (NYSE American: ELMD),
Read more →ELMDElectromed, Inc. Names John Erb and Greg Fluet to its Board of Directors New Prague, Minnesota
Electromed, Inc. Names John Erb and Greg Fluet to its Board of Directors New Prague, Minnesota - August 15, 2019 - Electromed, Inc. (NYSE American: ELMD), a leader in innovative airway clearance technologies, announced today that its Board of Directors has elected each of Joh
Read more →ELMDElectromed, Inc. Announces Fiscal 2019 Third Quarter Financial Results New Prague, Minnesota
Electromed, Inc. Announces Fiscal 2019 Third Quarter Financial Results New Prague, Minnesota - May 7, 2019 - Electromed, Inc. (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended March 31, 20
Read more →ELMDElectromed, Inc. Announces Fiscal 2019 Second Quarter Financial Results -- 15.1% year-over-year increase in revenue -- New Prague, Minnesota
Electromed, Inc. Announces Fiscal 2019 Second Quarter Financial Results -- 15.1% year-over-year increase in revenue New Prague, Minnesota - February 12, 2019 - Electromed, Inc. (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced finan
Read more →ELMDElectromed, Inc. Announces Fiscal 2019 First Quarter Financial Results -- 15.4% year-over-year increase in revenue -- New Prague, Minnesota
Electromed, Inc. Announces Fiscal 2019 First Quarter Financial Results -- 15.4% year-over-year increase in revenue New Prague, Minnesota - November 13, 2018 - Electromed, Inc. ("Electromed" or the "Company") (NYSE American: ELMD), a leader in innovative airway clearance tech
Read more →ELMDElectromed, Inc. Announces Fiscal 2018 Fourth Quarter Financial Results -- 14.8% year-over-year increase in home care revenue -- New Prague, Minnesota
Inc. Announces Fiscal 2018 Fourth Quarter Financial Results 14.8% year-over-year increase in home care revenue -- Prague, Minnesota - September 25, 2018 - Electromed, Inc. ("Electromed" or the "Company") (NYSE American: ELMD), a leader in innovative airway clearance technologi
Read more →ELMDElectromed, Inc. Announces Fiscal 2018 Third Quarter Financial Results New Prague, Minnesota
Inc. Announces Fiscal 2018 Third Quarter Financial Results Prague, Minnesota - May 8, 2018 - Electromed, Inc. ("Electromed" or the "Company") (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months end
Read more →ELMDElectromed, Inc. Announces Fiscal 2018 Second Quarter Financial Results -- 18.2% year-over-year increase in home care revenue -- New Prague, Minnesota
Electromed, Inc. Announces Fiscal 2018 Second Quarter Financial Results -- 18.2% year-over-year increase in home New Prague, Minnesota - February 13, 2018 - Electromed, Inc. ("Electromed" or the "Company") (NYSE American: ELMD), a leader in innovative airway clearance techno
Read more →ELMDElectromed, Inc. Announces Fiscal 2018 First Quarter Financial Results -- 16.5% year-over-year increase in home care revenue -- New Prague, Minnesota
Inc. Announces Fiscal 2018 First Quarter Financial Results 16.5% year-over-year increase in home care revenue -- Prague, Minnesota - November 7, 2017 - Electromed, Inc. ("Electromed" or the "Company") (NYSE American: ELMD), a leader in innovative airway clearance technologies,
Read more →ELMDElectromed, Inc. Announces Fiscal 2017 Fourth Quarter Financial Results -- 29.5% year-over-year increase in home care revenue -- New Prague, Minnesota
Inc. Announces Fiscal 2017 Fourth Quarter Financial Results 29.5% year-over-year increase in home care revenue -- Prague, Minnesota - September 5, 2017 - Electromed, Inc. ("Electromed" or the "Company") (NYSE MKT: ELMD), a leader in innovative airway clearance technologies, to
Read more →ELMDElectromed, Inc. Announces Fiscal 2017 Third Quarter Financial Results -- 13.5% year-over-year increase in home care sales -- New Prague, Minnesota
Electromed, Inc. Announces Fiscal 2017 Third Quarter Financial Results -- 13.5% year-over-year increase in home care New Prague, Minnesota - May 15, 2017 - Electromed, Inc. ("Electromed" or the "Company") (NYSE MKT: ELMD), a leader in innovative airway clearance technologies
Read more →ELMDElectromed, Inc. Announces Fiscal 2017 Second Quarter Financial Results -- Reports Record Revenue and Cash Flow from Operations -- New Prague, Minnesota
Electromed, Inc. Announces Fiscal 2017 Second Quarter Financial Results -- Reports Record Revenue and Cash Flow New Prague, Minnesota - February 7, 2017 - Electromed, Inc. ("Electromed" or "the Company") (NYSE MKT: ELMD), a leader in innovative airway clearance technologies,
Read more →ELMDElectromed, Inc. Announces Fiscal 2017 First Quarter Financial Results - Boosts R&D Investment to Develop Wireless Connectivity for the SmartVest SQL AirWay Clearance System New Prague, Minnesota
Electromed, Inc. Announces Fiscal 2017 First Quarter Financial Results - Boosts R&D Investment to Develop Wireless for the SmartVest SQL AirWay Clearance New Prague, Minnesota - November 8, 2016 - Electromed, Inc. ("Electromed" or "the Company") (NYSE MKT: ELMD), a leader in
Read more →ELMDJeremy Brock Chief Financial Officer Electromed, Inc. 952-758-9299 investorrelations@electromed.com Electromed, Inc. Reports Higher Fourth Quarter and Full Year Revenues and Profits Full Yea
Chief Financial Officer investorrelations@electromed.com Inc. Reports Higher Fourth Quarter and Full Year Revenues and Full Year Revenues up 18.5% Year over Year Full Year Earnings per Share of $0.27 Compared to $0.13 in Prior Year New Prague, Minnesota - September 6, 2016
Read more →ELMDJeremy Brock Chief Financial Officer Electromed, Inc. 952-758-9299 investorrelations@electromed.com Electromed, Inc. Reports another $6 Million Quarter Operating Income Increased 1178% New P
Chief Financial Officer investorrelations@electromed.com Electromed, Inc. Reports another $6 Million Quarter Operating Income Increased 1178% New Prague, Minnesota - May 10, 2016 - Electromed, Inc. (NYSE MKT: ELMD) today announced financial results for the three- and nine-m
Read more →ELMDJeremy Brock Chief Financial Officer Electromed, Inc. 952-758-9299 investorrelations@electromed.com Electromed, Inc. Reports Record $6 Million Dollar Quarter Operating Income Increased 180%
Chief Financial Officer investorrelations@electromed.com Inc. Reports Record $6 Million Dollar Quarter Operating Income Increased New Prague, Minnesota - February 9, 2016 - Electromed, Inc. (NYSE MKT: ELMD) today announced financial results for the three- and six-month perio
Read more →ELMDJeremy Brock Chief Financial Officer Electromed, Inc. 952-758-9299 investorrelations@electromed.com Electromed, Inc. Reports Higher First Quarter Revenues and Operating Income Operating Inco
Chief Financial Officer investorrelations@electromed.com Inc. Reports Higher First Quarter Revenues and Operating Income Income Increased 47% Prague, Minnesota - November 10, 2015 - Electromed, Inc. (NYSE MKT: ELMD) today announced financial results for its first quarter end
Read more →ELMDJeremy Brock Chief Financial Officer Electromed, Inc. 952-758-9299 investorrelations@electromed.com Electromed, Inc. Reports Higher Third Quarter Revenues and Profits New Prague, Minnesota
Chief Financial Officer investorrelations@electromed.com Electromed, Inc. Reports Higher Third Quarter Revenues New Prague, Minnesota - May 12, 2015 - Electromed, Inc. (NYSE MKT: ELMD) today announced financial results for the three- and nine-month periods ended March 31, 201
Read more →ELMDKathleen Skarvan Chief Executive Officer Electromed, Inc. 952-758-9299 kskarvan@electromed.com Electromed, Inc. Reports Higher Second Quarter Revenues and Profits New Prague, Minnesota
Chief Executive Officer kskarvan@electromed.com Electromed, Inc. Reports Higher Second Quarter Revenues and Profits New Prague, Minnesota - February 10, 2015 - Electromed, Inc. (NYSE MKT: ELMD) today announced financial results for the three-and six-month periods ended Decembe
Read more →ELMDKathleen Skarvan Chief Executive Officer Electromed, Inc. 952-758-9299 kskarvan@electromed.com Electromed, Inc. Reports Higher First Quarter Revenues and Profits New Prague, Minnesota
Chief Executive Officer kskarvan@electromed.com Electromed, Inc. Reports Higher First Quarter Revenues New Prague, Minnesota - November 12, 2014 - Electromed, Inc. (NYSE MKT: ELMD) today announced financial results for the three-month period ended September 30, 2014. Net reve
Read more →ELMDKathleen Skarvan Chief Executive Officer Electromed, Inc. 952-758-9299 kskarvan@electromed.com Electromed, Inc. Reports a Profit on Higher Fiscal 2014 Fourth Quarter Revenues New Prague, Min
Chief Executive Officer kskarvan@electromed.com Electromed, Inc. Reports a Profit on Higher Fiscal 2014 Fourth Quarter Revenues New Prague, Minnesota - September 23, 2014 - Electromed, Inc. (NYSE MKT: ELMD) today announced financial results for its fourth quarter and fiscal
Read more →ELMDKathleen Skarvan Chief Executive Officer kskarvan@electromed.com 952-758-9299 Electromed, Inc. Names Lee Jones to its Board of Directors New Prague, Minnesota
Chief Executive Officer kskarvan@electromed.com Electromed, Inc. Names Lee Jones to its Board of New Prague, Minnesota - September 2, 2014 -- Electromed, Inc. (NYSE MKT: ELMD), announced today that its Board of Directors has elected Lee Jones to the Board. Ms. Jones has serv
Read more →ELMDKathleen Skarvan Chief Executive Officer kskarvan@electromed.com 952-758-9299 Electromed, Inc. Board Member Announces Plans to Step Down from Board New Prague, Minnesota
Chief Executive Officer kskarvan@electromed.com Electromed, Inc. Board Member Announces Plans to Step Down from Board New Prague, Minnesota - May 22, 2014 - Electromed, Inc. (NYSE MKT: ELMD) announced today that Darrel Kloeckner, a member of the Company's Board of Directors
Read more →ELMDKathleen Skarvan Chief Executive Officer Electromed, Inc. 952-758-9299 kskarvan@electromed.com Electromed, Inc. Reports Higher Fiscal 2014 Third Quarter Revenues New Prague, Minnesota
Chief Executive Officer kskarvan@electromed.com Electromed, Inc. Reports Higher Fiscal 2014 Third Quarter Revenues New Prague, Minnesota - May 13, 2014 - Electromed, Inc. (NYSE MKT: ELMD) today announced financial results for the three-month period ended March 31, 2014. Net
Read more →ELMDKathleen Skarvan Chief Executive Officer Electromed, Inc. 952-758-9299 kskarvan@electromed.com ELECTROMED, INC. REPORTS FISCAL YEAR 2014 SECOND QUARTER RESULTS New Prague, Minnesota
Chief Executive Officer kskarvan@electromed.com ELECTROMED, INC. REPORTS FISCAL YEAR 2014 SECOND New Prague, Minnesota - February 11, 2014 - Electromed, Inc. (NYSE MKT: ELMD) today announced financial results for the Company's second quarter of fiscal 2014. Net revenues in t
Read more →ELMDKelly Lunder Manager of Marketing & Communications klunder@electromed.com 952-758-0382 Electromed, Inc. receives FDA Market Clearance for the SmartVest SQL TM New Prague, Minnesota
Manager of Marketing & Communications klunder@electromed.com Electromed, Inc. receives FDA Market Clearance for the SmartVest SQLTM New Prague, Minnesota - December 30, 2013 - Electromed, Inc. (NYSE MKT: ELMD), a global medical device company, today announced it has received
Read more →ELMDKathleen Skarvan Chief Executive Officer Electromed, Inc. 952-758-9299 kskarvan@electromed.com ELECTROMED, INC. REPORTS FISCAL YEAR 2014 FIRST QUARTER RESULTS New Prague, Minnesota
Chief Executive Officer kskarvan@electromed.com ELECTROMED, INC. REPORTS FISCAL YEAR 2014 FIRST QUARTER New Prague, Minnesota - November 12, 2013 - Electromed, Inc. (NYSE MKT: ELMD) today announced financial results for the three-month period ended September 30, 2013. Net rev
Read more →ELMDKathleen Skarvan Chief Executive Officer Electromed, Inc. 952-758-9299 kskarvan@electromed.com ELECTROMED, INC. REPORTS FISCAL YEAR 2013 FOURTH QUARTER AND YEAR END RESULTS New Prague, Minne
Chief Executive Officer kskarvan@electromed.com ELECTROMED, INC. REPORTS FISCAL YEAR 2013 FOURTH QUARTER AND YEAR END RESULTS New Prague, Minnesota - September 25, 2013 - Electromed, Inc. (NYSE MKT: ELMD) today announced financial results for the 2013 fourth quarter and fisc
Read more →ELMDKathleen Skarvan Chief Executive Officer Electromed, Inc. 952-758-9299 kskarvan@electromed.com ELECTROMED, INC. REPORTS FISCAL YEAR 2013 THIRD QUARTER RESULTS New Prague, Minnesota
Chief Executive Officer kskarvan@electromed.com ELECTROMED, INC. REPORTS FISCAL YEAR 2013 THIRD QUARTER New Prague, Minnesota - May 14, 2013 - Electromed, Inc. (NYSE MKT: ELMD) today announced financial results for the three-month period ended March 31, 2013. Net revenues for
Read more →ELMDKathleen Skarvan Chief Executive Officer Electromed, Inc. 952-758-9299 kskarvan@electromed.com ELECTROMED, INC. REPORTS FY2013 SECOND QUARTER RESULTS New Prague, Minnesota
Chief Executive Officer kskarvan@electromed.com ELECTROMED, INC. REPORTS FY2013 SECOND QUARTER New Prague, Minnesota - February 13, 2013 - Electromed, Inc. (NYSE MKT: ELMD) today announced financial results for the three-month period ended December 31, 2012. Net revenues for
Read more →ELMDStephen H. Craney Chairman of the Board Electromed, Inc. 507-452-5109 x 216 scraney@rellew.com BOARD OF DIRECTORS APPOINTS KATHLEEN SKARVAN AS CHIEF EXECUTIVE OFFICER OF ELECTROMED, INC. New
Chairman of the Board APPOINTS KATHLEEN SKARVAN AS CHIEF EXECUTIVE OFFICER OF ELECTROMED, INC. New Prague, Minnesota - November 29, 2012 - The Board of Directors of Electromed, Inc. announced today that Kathleen Skarvan has been appointed as the Company's Chief Executive Offi
Read more →ELMDJames J. Cassidy, Ph.D. Interim Chief Executive Officer Electromed, Inc. 952-758-9299 jcassidy@electromed.com ELECTROMED, INC. REPORTS FY2013 FIRST QUARTER RESULTS New Prague, Minnesota
James J. Cassidy, Ph.D. Interim Chief Executive Officer jcassidy@electromed.com ELECTROMED, INC. REPORTS FY2013 FIRST New Prague, Minnesota - November 13, 2012 - Electromed, Inc. (NYSE MKT: ELMD) today announced financial results for the three-month period ended September 30
Read more →ELMDElectromed Letterhead]
[Electromed Letterhead] I am writing to you in my role as the interim Chief Executive Officer of Electromed, Inc., having served in that capacity since the retirement of Robert D. Hansen in May 2012. I want to take this opportunity to address the current state of the Company a
Read more →ELMDJames J. Cassidy, Ph.D. Interim Chief Executive Officer Electromed, Inc. 952-758-0376 jcassidy@electromed.com Al Galgano Padilla Speer Beardsley 651-455-1720 agalgano@padillaspeer.com ELECTR
James J. Cassidy, Ph.D. Interim Chief Executive Officer jcassidy@electromed.com Padilla Speer Beardsley agalgano@padillaspeer.com ELECTROMED, INC. REPORTS FISCAL 2012 FOURTH-QUARTER AND YEAR-END RESULTS New Prague, Minn. - Sept. 24, 2012 - Electromed, Inc. (NYSE MKT: ELMD
Read more →ELMDJames J. Cassidy, Ph.D. Interim Chief Executive Officer Electromed, Inc. 952-758-9299 jcassidy@electromed.com Pankti Shah Director of Strategic Marketing The Event Group, Incorporated 763-54
James J. Cassidy, Ph.D. Interim Chief Executive Officer jcassidy@electromed.com Director of Strategic Marketing The Event Group, Incorporated pankti.shah@eventshows.com ELECTROMED, INC. REPORTS 2012 THIRD QUARTER New Prague, Minnesota - May 14, 2012 - Electromed, Inc. (NY
Read more →ELMDRobert D. Hansen Chairman and Chief Executive Officer Electromed, Inc. 952-758-9299 bhansen@electromed.com Pankti Shah Director of Strategic Marketing The Event Group, Incorporated 763-548-
Chairman and Chief Executive Officer bhansen@electromed.com Director of Strategic Marketing The Event Group, Incorporated pankti.shah@eventshows.com ELECTROMED, INC. REPORTS 2012 SECOND QUARTER New Prague, Minnesota - February 13, 2012 - Electromed, Inc. (NYSE Amex: ELMD)
Read more →ELMDRobert D. Hansen Chairman and Chief Executive Officer Electromed, Inc. 952-758-9299 bhansen@electromed.com Pankti Shah Director of Strategic Marketing The Event Group, Incorporated 763-548-1
bhansen@electromed.com Director of Strategic The Event Group, Incorporated pankti.shah@eventshows.com INC. PROVIDES GUIDANCE REGARDING OPERATING PERFORMANCE FOR SECOND FISCAL QUARTER AND LAST HALF OF 2012 New Prague, Minnesota - January 17, 2012 - After reporting a strong
Read more →ELMDELECTROMED, INC. Creating superior care through innovation FOR IMMEDIATE RELEASE Contact: Robert D. Hansen Chairman and Chief Executive Officer Electromed, Inc. 952-758-9299 bhansen@electromed.com Pankti Shah Director of
ELECTROMED, INC. Creating superior care through innovation FOR IMMEDIATE RELEASE Contact: Robert D. Hansen Chairman and Chief Executive Officer Electromed, Inc. 952-758-9299 bhansen@electromed.com Pankti Shah Director of Strategic Marketing The Event Group, Incorporated 763-548-1
Read more →ELMDELECTROMED, INC. Creating superior care through innovation FOR IMMEDIATE RELEASE Contacts: Robert D. Hansen Chairman and Chief Executive Officer Electromed, Inc. (952) 758-9299 bhansen@electromed.com The Event Group, Inc
Creating superior care through innovation Chairman and Chief Executive Officer bhansen@electromed.com The Event Group, Inc. pankti.shah@eventshows.com Electromed Announces Exercise of Over-allotment Option New Prague, MN September 29, 2010 Electromed, Inc. (NASDAQ: ELMD) an
Read more →ELMDElectromed, Inc. Announces Pricing of Initial Public Offering New Prague, Minnesota
Electromed, Inc. Announces Pricing of Initial Public Offering New Prague, Minnesota, August 13, 2010 Electromed, Inc. (Nasdaq: ELMD), which is a leader in developing innovative airway clearance therapy products for use by patients with compromised pulmonary function, today annou
Read more →Competitive Position
How ELMD ranks across every disease it competes inCompetitive Position is a premium feature
See how ELMD ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial